Table 1 Patient demographics and disease and treatment characteristics

With chronic kidney disease

66,476

13,445 [8.18]

53,031 [1.44]

Without chronic kidney disease

3,792,364

151,018

3,641,346

Age group, years

50-59

1,750,009

54,586 [33.19]

1,695,423

60-69

1,097,797

50,413 [30.65]

1,047,384

70-79

734,932

45,041 [27.39]

689,891

≥80

276,102

14,423 [8.77]

261,679

Sex

Male

1,863,738

125,311 [76.19]

1,738,427 [47.06]

Female

1,995,102

39,152

1,955,950

Comorbidities

Hypertension

419,678

45,693 [27.8]

373,985[10.1]

Hyperlipidemia

60,744

9,521 [5.8]

51,223 [1.4]

Smoking-related diagnosis

262,913

17,183 [10.4]

245,730 [6.7]

Alcoholism-related diagnosis

28,305

2,891 [1.8]

25,414 [0.7]

Uremia

21,526

2,228 [1.4]

19,298 [0.5]

Charlson’s comorbidities Index score†

0

3,099,342

106,542

2,992,800

1

494,593

35,179

459,414

2

178,885

14,215

164,670

3

50,181

5,264

44,917

4

16,497

1,858

14,639

5

5,752

659

5,093

6

2,360

261

2,099

7

1,269

101

1,168

8

6,321

204

6,117

9

2,384

100

2,284

10+

1,256

80

1,176

Follow-up in years

0

63,220

2,682

60,538

1

65,186

4,115

61,071

2

67,987

4,446

63,541

3

67,136

4,484

62,652

4

3,519,426

144,228

3,375,198

5

75,885

4,508

71,377